The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Bristol-Myers Squibb
 
Consulting or Advisory Role - Amgen; Lilly; Merck; MSD; Roche; SERVIER
Speakers' Bureau - Amgen; Bayer; Bristol-Myers Squibb; Lilly; Merck; MSD; Roche; SERVIER
Travel, Accommodations, Expenses - Amgen; Bayer; Merck; Roche; SERVIER
Adjuvant nivolumab (NIVO) in resected esophageal or gastroesophageal junction cancer (EC/GEJC) following neoadjuvant chemoradiotherapy (CRT): Expanded efficacy and safety analyses from CheckMate 577.
 
Ronan Joseph Kelly
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Daiichi Sanyo; Eisai; EMD Serono; Lilly; Medscape; Merck; Novartis; Onc Live; Peerview; Pieris Pharmaceuticals; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Lilly (Inst)
 
Jaffer A. Ajani
Honoraria - Acrotech Biopharma; Aduro Biotech; Amgen; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo; DAVA Pharmaceuticals; Lilly; Merck; OncoTherics; zymeworks
Consulting or Advisory Role - American Cancer Society; BeiGene; Bristol-Myers Squibb; Insys Therapeutics; Merck; Vaccinogen
Research Funding - Amgen; Astellas Pharma (Inst); Bristol-Myers Squibb; Daiichi Sankyo; Delta-Fly Pharma; Gilead Sciences; Lilly/ImClone; Merck; Novartis; ProLynx; Roche/Genentech; Taiho Pharmaceutical; Takeda; Zymeworks
Patents, Royalties, Other Intellectual Property - I have research funding from: Genentech, Roche, BMS, Taiho, MedImmune, Merck, Amgen, Lilly
 
Jaroslaw Kuzdzal
Honoraria - Bristol-Myers Squibb; Roche
Research Funding - Bristol-Myers Squibb (Inst); Roche (Inst)
 
Thomas Zander
Consulting or Advisory Role - BMS; MSD Oncology; Novartis; Pfizer; Roche
 
Eric Van Cutsem
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Bayer; Biocartis; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; GlaxoSmithKline; Halozyme; Incyte; Lilly; Merck KGaA; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche; SERVIER; Sirtex Medical; Taiho Pharmaceutical
Research Funding - amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Merck KGaA (Inst); Novartis (Inst); Roche (Inst); SERVIER (Inst)
 
Guillaume Piessen
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; Nestle health science; Roche; Stryker
Travel, Accommodations, Expenses - medtronic
(OPTIONAL) Uncompensated Relationships - Medtronic
 
Guillermo Mendez
No Relationships to Disclose
 
Josephine Louella Feliciano
Consulting or Advisory Role - AstraZeneca; bristol myers; Genentech; Lilly; Lilly; Merck; Pfizer
Research Funding - AstraZeneca (Inst); Bristol Myers (Inst); genentech; Merck
 
Satoru Motoyama
Consulting or Advisory Role - Ono Pharmaceutical
Speakers' Bureau - Ono Pharmaceutical
 
Astrid Lièvre
Honoraria - Advanced Accelerator Applications; Amgen; Bayer; Bristol-Myers Squibb; HalioDx; Ipsen; Merck; Novartis; Pierre Fabre; Roche; Sandoz; Sanofi; SERVIER
Consulting or Advisory Role - Advanced Accelerator Applications; Amgen; Bayer; Incyte; Ipsen; Merck; Novartis; Pierre Fabre; Roche; Sandoz; Servier
Research Funding - IntegraGen; Novartis
Travel, Accommodations, Expenses - Advanced Accelerator Applications; Bayer; Bristol-Myers Squibb; Incyte; Ipsen; Merck; Novartis; Pfizer; Roche; Sandoz; SERVIER
 
Hope Elizabeth Uronis
Employment - GeneCentric (I)
Stock and Other Ownership Interests - GeneCentric (I)
Consulting or Advisory Role - AstraZeneca
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Leap Therapeutics; Macrogenics (Inst); Merck (Inst)
 
Elena Elimova
Employment - Merck (I)
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Zymeworks (Inst)
Research Funding - Bristol-Myers Squibb; Zymeworks
 
Cecile Grootscholten
No Relationships to Disclose
 
Karen Paula Geboes
Consulting or Advisory Role - Ipsen; MSD; SERVIER
Research Funding - Vifor Pharma (Inst)
Expert Testimony - Merck KGaA
Travel, Accommodations, Expenses - Ipsen; Roche; SERVIER
 
Jenny Zhang
No Relationships to Disclose
 
Samira Soleymani
Employment - Bristol-Myers Squibb
 
Ming Lei
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - Bristol-Myers Squibb
 
Prianka Singh
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
James M. Cleary
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Abbvie (Inst); AstraZeneca; BMS (Inst); BMS (Inst); Esperas Pharma; Merck; Merus (Inst); Roche/Genentech (Inst); Tesaro
Travel, Accommodations, Expenses - Agios; Bristol-Myers Squibb; Roche
 
Markus H. Moehler
Honoraria - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck Serono; MSD Oncology; Pierre Fabre; Roche/Genentech; Sanofi; Servier
Consulting or Advisory Role - Amgen; Bayer; BeiGene; BMS; Lilly; Merck Serono; MSD; Pfizer; Roche; SERVIER; Taiho Pharmaceutical
Research Funding - Amgen (Inst); AstraZeneca (Inst); Leap Therapeutics (Inst); Merck Serono (Inst); MSD (Inst)
Travel, Accommodations, Expenses - Amgen; ASCO; Bayer; ESMO; German Cancer Society; Merck Serono; MSD; Roche